End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,005 KRW | -1.95% |
|
-1.37% | -65.34% |
Business Summary
Number of employees: 363
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
72.1
%
| 64,743 | 99.3 % | 62,954 | 72.1 % | -2.76% |
Bio
19.3
%
| 274 | 0.4 % | 16,870 | 19.3 % | +6,047.42% |
Insulation
7.3
%
| - | - | 6,369 | 7.3 % | - |
Other
0.9
%
| - | - | 812 | 0.9 % | - |
Game
0.4
%
| 173 | 0.3 % | 358 | 0.4 % | +106.48% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 65,190 | 100.0 % | 87,364 | 100.0 % | +34.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 68 | 01/12/01 |
Yun-Gyeong Bae
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Jong-Su Gang
BRD | Director/Board Member | 60 | - |
Sung-Ho Kang
SAM | Sales & Marketing | 58 | - |
Min-Cheol Jeong
AUD | Comptroller/Controller/Auditor | 67 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 68 | 01/12/01 |
Jong-Su Gang
BRD | Director/Board Member | 60 | - |
Yun-Gyeong Bae
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Dong-chul Shin
BRD | Director/Board Member | 63 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,328,549 | 20,261,633 ( 15.31 %) | 10,470,836 ( 7.913 %) | 15.31 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
AP HEALTHCARE INC. 42.00% | 47,945,206 | 42.00% | 24,863,425 $ |
APROGEN BIOLOGICS INC. 0.79% | 1,048,749 | 0.79% | 907,441 $ |
APROGEN MEDICINES INC. -.--% | 0 | -.--% | 0 $ |
Company contact information
Aprogen Biologics, Inc.
Room 301 Gangho Building 6 Ogeum-ro 19-gil
06735, Seoul
+
http://www.aprogen-pharm.com![address Aprogen Biologics Inc.(A003060)](https://cdn.zonebourse.com/static/address/20699894.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-65.34% | 47.95M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- A003060 Stock
- Company Aprogen Biologics Inc.